Senior Airman Joshua Rosario/59th Medical Wing
/
Digital
A month after flu shots became voluntary, influenza began to burn through boot camp at Lackland Air Force Base. Hundreds have been sickened, and infectious diseases experts are not surprised.
-
Cataracts affect about 24 million Americans. A North Texas doctor explains what they are, what causes them and how you can address the problem. -
Around 13% of Bexar residents over the age of 65 are living with the disease. -
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal. -
Alcohol use disorder affects millions of Americans, but treatment options remain limited, and relapse is common. A UT Health San Antonio researcher is studying two unconventional approaches that he hopes could one day be combined into a single, more effective treatment.
-
One of the world's leading brain research centers is shifting away from fruit flies and toward a tiny, transparent fish. The goal: to understand how brains control the behavior of an animal or human. -
Science & Medicine: Relaxing excited neurons may lead to more effective treatments for schizophreniaA new medication to treat schizophrenia has been developed by scientists who discovered that a neuron that inhibits the activity of other cells may be in short supply in those with the disorder.
-
A study of more than 2,300 9- to 10-year-olds found that socioeconomic factors explained most differences in the preteens' brain development. -
Texas A&M AgriLife livestock entomologist Sonja Swiger discusses the risks New World screwworm poses to pets, people and livestock, addresses concerns about the food supply and explains why reporting infestations is critical. -
Around 17% of service members who deploy to combat zones come home with PTSD — and for many, the road to recovery is long, difficult, and often out of reach. A new study hopes to change that by pairing a single dose of MDMA — known colloquially as ecstasy — with intensive therapy, potentially compressing recovery into just two weeks.
-
The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it.
